An International Scientific Congress
Challenges of Early Crossover in Clinical Trial Design for Oncology
On Wednesday 22 October 2014, Bellberry will host a Congress in Adelaide on the Challenges of Early Crossover in Clinical Trial Design for Oncology. At this important event, Bellberry will launch guidelines in this area which have been consolidated by an international panel of experts at a workshop overseen by a Scientific Advisory Committee, chaired by Emeritus Professor Lloyd Sansom AO.
The workshop will result in the development of an agreed statement of good practice, guidelines on approaches and clear agreement on any required next steps, all of which will be presented and debated at the conference.
Including representatives from:
Australian Government Department of Health
CADTH - Canadian Agency for Drugs and Technologies in Health
Consumer representatives
EMA - European Medicines Agency
EUNetHTA - European Network of Health Technology Assessment
Health Canada
IQWIQ - Institute for Quality and Efficiency in Health Care - Germany
NHMRC - National Health & Medical Research Council
NICE - National Institute for Health & Care Excellence
PBAC - Pharmaceutical Benefits Advisory Committee
PBS - Pharmaceutical Benefits Scheme
TGA - Therapeutic Goods Administration
Wednesday 22 October
9.00am-4.30pm
Adelaide Hilton Hotel
Victoria Square
$200 (+gst) per person
Register at www.bellberry.com.au
Download conference brochure here
